Recent Patents on Anti-Infective Drug Discovery

Editor-in-Chief:

Dieter Kabelitz
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
Germany

Back

Become EABM
Become Reviewer

Most Accessed Articles

Short Antimicrobial Peptides

Volume: 13   Issue: 1
Pp: 12-52
Komal Sharma, Shams Aaghaz, Kitika Shenmar and Rahul Jain*
DOI: 10.2174/1574891X13666180628105928

Amarogentin as Topical Anticancer and Anti-Infective Potential: Scope of Lipid Based Vesicular in its Effective Delivery

Volume: 14   Issue: 1
Pp: 7-15
Kanika Patel, Vikas Kumar, Amita Verma, Mahfoozur Rahman* and Dinesh K. Patel*
DOI: 10.2174/1574891X13666180913154355

Nano-emulgel: Emerging as a Smarter Topical Lipidic Emulsion-based Nanocarrier for Skin Healthcare Applications open access plus

Volume: 14   Issue: 1
Pp: 16-35
Kumar Anand*, Subhabrata Ray, Mahfoozur Rahman, Adil Shaharyar, Rudranil Bhowmik, Rammohan Bera and Sanmoy Karmakar
DOI: 10.2174/1574891X14666190717111531

Perspective in Topical Infective and Non-infective Skin Diseases Therapy with Emergence of Nanomedicine promotion: free to download

Volume: 14   Issue: 1
Pp: 3-4
Mahfoozur Rahman* and Sarwar beg
DOI: 10.2174/1574891X1401191021171205

Lyme Neuroborreliosis - The Mystifying Pitfall: “Neuropathology and Current Therapeutics” open access plus

Volume: 14   Issue: 1
Pp: 49-68
Vishal Chavda and Snehal Patel*
DOI: 10.2174/1574891X14666190327114641

Polymyxin Resistance Mechanisms: From Intrinsic Resistance to Mcr Genes

Volume: 13   Issue: 3
Pp: 198-206
Georgios Meletis* and Lemonia Skoura
DOI: 10.2174/1574891X14666181126142704

Topical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization open access plus

Volume: 14   Issue: 1
Pp: 36-48
Javed Ahmad*, Anuj Gautam, Shahadali Komath, Mehdiya Bano, Anuj Garg and Keerti Jain
DOI: 10.2174/1574891X14666181129115213

Emerging Drugs for the Treatment of Human Immunodeficiency Virus promotion: free to download

Volume: 7   Issue: 1
Pp: 45-52
Girish M. Bhopale
DOI: 10.2174/157489112799829729

Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients

Volume: 13   Issue: 3
Pp: 190-197
Niccolò Riccardi, Marco Berruti, Filippo Del Puente, Lucia Taramasso and Antonio Di Biagio*
DOI: 10.2174/1574891X13666181031120019